Prosthetic aortic valve evaluation: Should the assessment of hemodynamic performance during exercise complete the analysis?  by Mannacio, Vito et al.
Letters to the Editor3. Varlotto JM, Recht A, Flickinger JC, Medford-
Davis LN, Dyer AM, DeCamp MM. Varying recur-
rence rates and risk factors associated with different
definitions of local recurrence in patients with sur-
gically resected, stage I nonsmall cell lung cancer.
Cancer. 2010;116:2390-400.
4. Fibla JJ, Cassivi SD, Brunelli A, Decker PA,
Allen MS, Darling GE, et al. Re-evaluation of the
prognostic value of visceral pleura invasion in stage
IB non-small cell lung cancer using the prospective
multicenter ACOSOG Z0030 trial data set. Lung
Cancer. 2012;78:259-62.
http://dx.doi.org/10.1016/
j.jtcvs.2013.04.048PROSTHETIC AORTIC VALVE
EVALUATION: SHOULD THE
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EXERCISE COMPLETE THE
ANALYSIS?
To the Editor:
In a recent publication, Suri and
colleagues1 evaluated the hemody-
namic performance of the latest
generation of biologic aortic valve
prostheses. The results evidenced
small but consistent early postopera-
tive hemodynamic differences among
current third-generation bioprostheses
(Edwards Magna, Sorin Mitroflow,
and St Jude Epic). We read the article
with interest and were also impressed
byDrDavid’s comment in themeeting
discussion. We congratulate Suri and
colleagues1 on this study; however,
we would like to add some comments.
First, Suri and colleagues1 likely
included in their study any type of
aortic valve disease, which could be
misleading for comparative results.
Aortic stenosis, aortic incompetence,
and their combination have differ-
ences in physiology, histology, and
anatomy, leading to different beha-
viors after the valve replacement.
Second, patients were assessed for
hemodynamic performance before
hospital discharge. This is contrary
to previous studies, which indicate
that in vivo values should be taken at
1-year follow-up because gradients
may change during the first postoper-
ative year, with significant impact onThe Journaleither the hemodynamic results or
the exercise capacity.2
Third, any realistic assessment of
hemodynamic behavior of a pros-
thesis should include evaluation
during exercise. Results obtained
under stress are by far more suitable
to evaluate the performance of a
valve type than hemodynamic data
obtained at rest, and they also reflect
more closely the situation in daily
life. In this regard, Gerosa and
colleagues3 used the Sheffield pulse
duplicator to demonstrate in vitro
that different prostheses perform
differently in different hemodynamic
circumstances. In vivo evaluations
are even more difficult. Stress-
induced echocardiographic assess-
ment could be hindered by several
confounding factors: heart rate,
cardiac output, left ventricle diastolic
pattern, hypertension, reduced sys-
temic arterial compliance, and so on.
In a recent study, we evaluated by
echocardiography the hemodynamic
performance at rest and during exer-
cise of 2 different aortic prostheses
of similar size implanted in patients
who underwent surgery for pure aortic
stenosis.4 Although the study
compared a mechanical valve with a
porcine bioprosthesis, our results
validated the technical procedures as
model for evaluations under stress.
As we were aware that the sole
measurement of gradients does
not entirely represent the complex
function of a valve during physical
exercise, we also analyzed the
stress-induced abnormalities of the
cardiac cycle 1 year after aortic valve
replacement. As is widely known, the
total cardiac cycle duration is alge-
braically dependent on the heart rate
(60,000 ms/heart rate), which is the
major determinant affecting diastolic
and systolic duration. Systolic time
has a negative linear correlation with
heart rate. Diastolic time is longer at
low heart rates and decreases more
markedly than systolic time during
exercise. Transprosthetic gradient is
a function of both diastolic durationof Thoracic and Cardiovascular Surgerand systolic/diastolic ratio, which
depends on a number of cofactors
but could also be attributed to the
flexibility of the stent and the geomet-
ric design of the bioprostheses.
These factors interfere with the
delicate physiologic mechanism of
active annulus motion and aortic root
expansion at each phase of the cardiac
cycle, especially during exercise. This
is more valid for mechanical valves
and for 19- to 23-mm bioprostheses.
A meaningful evaluation of a bio-
prosthesis should therefore further
consider the stent flexibility during
exercise and the effective tolerability
of its distortion when upsized.
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To the Editor:
Todman and associates1 recently
described favorable outcomes aftery c Volume 146, Number 5 1307
